Durvalumab, with or without tremelimumab, plus platinum-etoposide versus platinum-etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN) update...

Goldman Jonathan W, Dvorkin Mikhail, Chen Yuanbin, Kollaborációs szervezet: CASPIAN investigators, Losonczy György, Horváth Zsolt, Pajkos Gábor, Bogos Krisztina, Somfay Attila, Pápai Székely Zsolt, Sárosi Veronika, Fülöp Andrea, Laczó Ibolya, Kósa Judit, Telekes András, Csánky Eszter, Somogyiné Ezer Éva, Pápai Zsuzsanna
2021

Durvalumab plus platinum-etoposide versus platinum-etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN) a randomised, controlled, open-label, phase...

Paz-Ares Luis, Dvorkin Mikhail, Chen Yuanbin, Reinmuth Niels, Hotta Katsuyuki, Trukhin Dmytro, Statsenko Galina, Hochmair Maximilian J, Özgüroğlu Mustafa, Ji Jun Ho, Voitko Oleksandr, Poltoratskiy Artem, Ponce Santiago, Verderame Francesco, Havel Libor, Bondarenko Igor, Kazarnowicz Andrzej, Losonczy György, Conev Nikolay V, Armstrong Jon, Byrne Natalie, Shire Norah, Jiang Haiyi, Goldman Jonathan W, Kollaborációs szervezet: CASPIAN investigators, Somfay Attila, et al
2019

Osimertinib in Resected EGFR-Mutated Non–Small-Cell Lung Cancer

Wu Yi-Long, Tsuboi Masahiro, He Jie, John Thomas, Grohe Christian, Majem Margarita, Goldman Jonathan W., Laktionov Konstantin, Kim Sang-We, Kato Terufumi, Vu Huu-Vinh, Lu Shun, Lee Kye-Young, Akewanlop Charuwan, Yu Chong-Jen, de Marinis Filippo, Bonanno Laura, Domine Manuel, Shepherd Frances A., Zeng Lingmin, Hodge Rachel, Atasoy Ajlan, Rukazenkov Yuri, Herbst Roy S., Kollaborációs szervezet: ADAURA Investigators, Somfay Attila, et al
2020